Combined simultaneous embolization of the portal vein and hepatic vein (double vein embolization) - a technical note about embolization sequence.

Embolization Future liver remnant Hepatic vein Portal vein

Journal

CVIR endovascular
ISSN: 2520-8934
Titre abrégé: CVIR Endovasc
Pays: Switzerland
ID NLM: 101738484

Informations de publication

Date de publication:
26 May 2021
Historique:
received: 29 12 2020
accepted: 06 05 2021
entrez: 26 5 2021
pubmed: 27 5 2021
medline: 27 5 2021
Statut: epublish

Résumé

Simultaneous portal vein embolization (PVE) and hepatic vein embolization (HVE) has been shown to be feasible, safe and lead to a faster growth of future liver remnant (FLR) than PVE alone. The objective of this study is to highlight different technical aspects as well as importance of embolization order. Seven patients were treated with simultaneous PVE and HVE. In three cases, HVE was performed first followed by PVE and in four cases the other way around. Portal vein branches were embolized using Glubran-Lipiodol mixture in all cases. Hepatic veins were embolized using Amplatzer II plugs sized 8-20 mm. Specific consideration was given to depth of glue penetration in the portal vein defined by visible branch order on the treated side. Six of seven patients were discharged home the same day. One patient with infected tumor necrosis died of liver failure 40 days later, otherwise there were no periprocedural clinical complications. Median glue penetration was to the 5th order (4th - 5th) when PVE was performed first and 3rd order (2nd - 4th) when PVE was performed after HVE. In one PVE first case, glue spillage was seen due to marked reduced flow in the right portal vein. There was sufficient FLR growth for subsequent surgical resection in the remaining six patients. PVE should be performed prior to HVE because the reduced flow in the portal vein after HVE leads to less deep glue penetration with presumably increased risk of contralateral spillage.

Sections du résumé

BACKGROUND BACKGROUND
Simultaneous portal vein embolization (PVE) and hepatic vein embolization (HVE) has been shown to be feasible, safe and lead to a faster growth of future liver remnant (FLR) than PVE alone. The objective of this study is to highlight different technical aspects as well as importance of embolization order.
MATERIALS AND METHODS METHODS
Seven patients were treated with simultaneous PVE and HVE. In three cases, HVE was performed first followed by PVE and in four cases the other way around. Portal vein branches were embolized using Glubran-Lipiodol mixture in all cases. Hepatic veins were embolized using Amplatzer II plugs sized 8-20 mm. Specific consideration was given to depth of glue penetration in the portal vein defined by visible branch order on the treated side.
RESULTS RESULTS
Six of seven patients were discharged home the same day. One patient with infected tumor necrosis died of liver failure 40 days later, otherwise there were no periprocedural clinical complications. Median glue penetration was to the 5th order (4th - 5th) when PVE was performed first and 3rd order (2nd - 4th) when PVE was performed after HVE. In one PVE first case, glue spillage was seen due to marked reduced flow in the right portal vein. There was sufficient FLR growth for subsequent surgical resection in the remaining six patients.
CONCLUSION CONCLUSIONS
PVE should be performed prior to HVE because the reduced flow in the portal vein after HVE leads to less deep glue penetration with presumably increased risk of contralateral spillage.

Identifiants

pubmed: 34037882
doi: 10.1186/s42155-021-00230-w
pii: 10.1186/s42155-021-00230-w
pmc: PMC8155155
doi:

Types de publication

Journal Article

Langues

eng

Pagination

43

Références

Cardiovasc Intervent Radiol. 2013 Feb;36(1):25-34
pubmed: 22806245
J Vasc Interv Radiol. 2019 Aug;30(8):1168-1184.e1
pubmed: 31229333
Eur Radiol. 2017 Aug;27(8):3343-3352
pubmed: 28101681
Eur Radiol. 2016 Dec;26(12):4259-4267
pubmed: 27090112
Curr Oncol Rep. 2020 May 16;22(6):59
pubmed: 32415401
Surgery. 2020 Jun;167(6):917-923
pubmed: 32014304

Auteurs

Arash Najafi (A)

Department of Radiology and Nuclear Medicine, Kantonsspital Winterthur, Brauerstrasse 15, 8401, Winterthur, Switzerland. najafi.arash@gmail.com.

Erik Schadde (E)

Department of Surgery, Kantonsspital Winterthur, Winterthur, Switzerland.

Christoph A Binkert (CA)

Department of Radiology and Nuclear Medicine, Kantonsspital Winterthur, Brauerstrasse 15, 8401, Winterthur, Switzerland.

Classifications MeSH